The Heptares platform will complement the existing technologies of the Group subsidiaries: Activus' nanoparticle technology (APNT), and Jitsubo's novel peptide manufacturing technology (Molecular Hiving™) and peptide modification technology (Peptune™).
These technologies are expected to generate synergies in the effort to identify new compounds, and to further strengthen the pipeline and enhance corporate value.